Loss of SMARCA4 function in MCL results in loss of chromatin accessibility at the ATF3 locus, leading to reduced expression of ATF3, which is a direct repressor of BCL-xL expression65. The gene discussed is ATF3; the disease is mantle cell lymphoma.